CAS RN: 778-24-5
Dimethyldiphenylsilane
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
≥97%(GC) (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20251226
250mg / 1g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 25g
Available purity: >97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 778-24-5
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
25g
>97%
0
Out of Stock
Shanghai
Inquiry
778-24-5 / dimethyl(diphenyl)silane
Standard CAS: 778-24-5
Multi CAS: No
Basic Information
copy
CAS
778-24-5 copy
Multi CAS
No copy
Molecular Formula
C14H16Si copy
Molecular Weight
212.360000 copy
Exact Mass
212.102127 copy
InChI
InChI=1S/C14H16Si/c1-15(2,13-9-5-3-6-10-13)14-11-7-4-8-12-14/h3-12H,1-2H3 copy
InChIKey
WJKVFIFBAASZJX-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
15 copy
Aromatic heavy atom count
12 copy
Fraction Csp3
0.14 copy
Rotatable bonds
2 copy
Molar refractivity
69.63 copy
TPSA
0.0000 copy
LogP / Solubility
WLOGP
2.51 copy
MLOGP
2.21 copy
XLogP3
2.51 copy
Consensus LogP
2.41 copy
Log S (ESOL)
-3.2 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.11 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.36 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.23 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy